Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

First Look: Distinct Infrastructure (V.DUG)

I missed Lite Access Technologies (LTE.C). Actually, that's not the right way to put it - I called Lite Access as a nice little opportunity back when it was unknown and plunging to $0.42 and struggling to raise cash as they plodded through small city contracts to upgrade...

Find Out Why this Uranium Junior Mining Company Has a Distinctive Competitive Advantage

Skyharbour Resources (TSX.V: SYH | OTCQB: SYHBF) Jordan Trimble the CEO of Skyhabour Resources sits down with Maurice Jackson of Proven and Probable to discuss a number of catalyst’s that are emerging in the uranium ...

Is a Local Top in Gold At Hand?

In yesterday’s analysis on gold price in December 2019 , we wrote that while the outlook for the yellow metal for the following months was bearish, it was bullish for the short term. And indeed – gold, silver, and mining stocks rallied. In fact, the rally cont...

InMed Shares Trade Up 25% After Becoming First to Advance Cannabinol into Clinical Trials

InMed Pharmaceuticals shares traded 25% higher after reporting that it is the first to advance cannabinol into therapeutic clinical trials. Vancouver-based clinical stage biopharmaceutical company InMed Pharmaceuticals Inc. (IN:TSX; IMLFF:OTCQX) , which is engaged in...

Stock Bottom Reached? Don’t Bet the Farm Just Yet

As the markets grapple with the coronavirus story, the stock market is no exception. Jittery and volatile trading is what we’ve seen on Friday, January 24 already. In the heat of the moment, it’s easy to sell first and ask questions later. But t...

Stock Bottom Reached? Don’t Bet the Farm Just Yet

As the markets grapple with the coronavirus story, the stock market is no exception. Jittery and volatile trading is what we’ve seen on Friday, January 24 already. In the heat of the moment, it’s easy to sell first and ask questions later. But t...

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data

Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. ...

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. In a May 26 research note, ROTH Capital Partners analyst Tony Butler purported that Atara Biotherapeutics Inc.'s (ATRA:NASDAQ) "updated data from the Phase 1 ...

dynaCERT on Haywood Securities’ radar, ESG benefactor ready to scale

dynaCERT Inc. (TSX-V: DYA) (OTCQB: DYFSF) (Frankfurt: DMJ) is the subject of coverage by analysts at Haywood Securities which issued an ‘Uncovered Radar Flash – Watchlist Report’ on June 2, 2020 entitled “ An ESG Benefactor; A Carbon Emission Reduction Techno...

Canadian Bitcoin portal stresses accessibility and independence

The Bitcoin world has experienced vast and rapid advancements, transforming from a niche digital currency into a mainstream financial asset. From its inception as a decentralized form of money, Bitcoin has evolved into a dynamic ecosystem, driving innovation in block...
1 2 3 4 5 6 7 8 9 10 ...